Heritage Pharmaceuticals Inc. is paying a relatively small sum to be free of the US Department of Justice's industry wide probe of generic price fixing. It remains to be seen if other generic manufacturers will enter similar settlements and how great their liability might be.
Heritage agreed to pay $7.1m to resolve allegations under the False Claims Act that it engaged in a price-fixing conspiracy....